Search Login Register
xaliproden
Summary
Also Known As:
1-(2-(naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride; 1-(2-(naphth-2-yl)ethyl)-4-(trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride; SR 57746A; SR-57746A; SR57746A Show All >>
Networked: 14
relevant articles (1 outcomes,
5 trials/studies)
for this Bio-Agent
Key Diseases for which xaliproden is
Relevant
-
Neurodegenerative Diseases (Neurodegenerative Disease)
:
1 outcome 1 study in 2 results
-
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
:
3 studies in 4 results
-
Alzheimer Disease (Alzheimer's Disease)
:
1 study in 2 results
-
Hyperalgesia
:
1 study in 1 result
-
Disease Progression
:
1 result
Show All >>
Drugs Related to xaliproden
-
5-HT1A Serotonin Receptor
-
Vincristine (Oncovin)
-
Paclitaxel (Taxol)
-
gabapentin (Neurontin)
-
oxaliplatin (Eloxatin)
-
xaliproden
-
GTP-Binding Proteins (G-Protein)
-
Amyloid beta-Peptides
-
Transforming Growth Factor beta (TGF-beta)
-
Serotonin (5 Hydroxytryptamine)
Show All >>
Therapies Related to xaliproden
-
Drug Therapy (Chemotherapy)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.